HeartFocus Clinical Trial Proves AI Can Empower Novices to Deliver Diagnostic-Quality Cardiac Ultrasounds
Results confirm HeartFocus as a reliable tool for expanding access to cardiac care
Results confirm HeartFocus as a reliable tool for expanding access to cardiac care
CHICAGO, Illinois – HeartFocus, the revolutionary, AI-enabled heart echo software developed by data-driven image analysis company DESKi released results from an international clinical trial validating that echocardiogram novices, guided by HeartFocus’ real-time AI, can capture diagnostic-quality heart scans after only brief training.
The results, which support HeartFocus’ mission to expand access to critical heart disease diagnostics by demonstrating that any healthcare professional can be empowered to conduct medical-grade cardiac scans, were presented as an abstract by Cardiologist and Assistant Professor of Cardiology at Northwell Health, Dr. Caroline Ong, during a late-breaking clinical trials session at the American College of Cardiology’s Annual Scientific Session & Expo (ACC.25) in Chicago.
The multi-center and non-randomized trial was conducted in collaboration between Northwell Health in the United States, University Hospital of Bordeaux (CHU) in France, and DESKi, HeartFocus’ parent company headquartered in Bordeaux.
A total of 240 adult patients underwent two ultrasound exams: one performed by an expert (a trained sonographer or cardiologist) and one by a novice using HeartFocus AI guidance. Five cardiologists blind-reviewed both exams to evaluate whether the images were of sufficient quality to visually analyze left ventricular size and function, the right ventricular size, and the presence of non-trivial pericardial effusion.
Results showed that 100% of exams conducted by novices using HeartFocus met the diagnostic standards for all primary endpoints, with a strong correlation to expert-acquired scans across qualitative and quantitative assessments.
“I could not be more proud of the trial's incredible outcomes, and excited by the prospects it brings for heart disease detection, prevention and management,” said Bertrand Moal, PhD, MD, and CEO of DESKi. “The trial proved that we can safely and effectively extend cardiac imaging capabilities to more providers, more settings, and more patients. I’m grateful for the collaboration of Northwell Health, University Hospital of Bordeaux (CHU), and all the abstract authors for their unwavering dedication.”
To read the abstract, Artificial Intelligence Empowers Novice Users to Acquire Diagnostic-Quality Echocardiography visit www.heartfocus.ai/acc-25-clinical-trial-result, or to learn more about HeartFocus, visit www.heartfocus.ai.
About HeartFocus
HeartFocus is a revolutionary, AI-driven heart exam software that empowers any healthcare professional to perform world-class echos from any device, anywhere. Created in 2023 by French brothers Bertrand and Olivier Moal, HeartFocus leverages proprietary and ground-breaking algorithms trained on over 10 million data points and validated through clinical trials. Bertrand, a Medical Doctor with a PhD in biomechanical engineering, and Olivier, a Berkeley and EPFL engineering alum, were moved by the devastating impact of cardiovascular disease exacerbated by increasingly overburdened healthcare systems. Driven by the belief No heart can wait ™, HeartFocus provides a life-saving solution for heart patients, facilitating early detection and disease prevention. In 2024, HeartFocus was awarded the coveted France 2030 Award by the French Ministry of Health and is currently partnered with several app platforms and Software Development Kit providers, including Butterfly Network in the US, to bring the technology to healthcare providers globally.
HeartFocus is the latest offering by DESKi, a provider of innovative AI products developed in conjunction with medical practitioners and researchers. For more information visit www.heartfocus.ai
Find More:
Cardiovascular Ambulatory Surgery Centers (ASCs) Topic Center
The Latest Clinical & Industry News
Grand Rounds With Morton Kern, MD
Peripheral Artery Disease Topic Center
